Asia-Pacific Hemodynamic Monitoring Market (2018-2023): The Increase in Number of Critically Ill Geriatric Population is Driving Growth - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Asia-Pacific Hemodynamic Monitoring Market - Segmented by System Type, by Application, by Product Type, and by Region - Growth, Trends, and Forecasts (2018-2023)” report has been added to ResearchAndMarkets.com’s offering.
The Asia-Pacific Hemodynamic Monitoring Market is expected to witness a robust growth due to the increase in the number of critically ill geriatric population, and a rise in the prevalence of cardiac disorders and diabetes.
Increase in the Number of Critically Ill Geriatric Population to Propel Growth of the Market
Increasing critically ill geriatric population is one of the important drivers propelling the growth of the hemodynamic monitoring market.
The elderly population currently accounts for almost 50% of the ICU admissions. These patients require continuous monitoring of their vital parameters.
Early and effective hemodynamic management with fluid therapy and administration of vasoactive drugs to maintain vital organ perfusion and oxygen delivery is mandatory in critically ill patients. This is expected to increase the demand for hemodynamic monitoring, which in turn, may drive the Asia-Pacific hemodynamic monitoring market.
Rising Incidences of Complications Associated With Invasive Monitoring Systems to Restrain Growth of the Market
Invasive hemodynamic monitoring is quite expensive and time-consuming, which may act as restraining factors for the global hemodynamic monitoring market.
Other major complications associated with an invasive monitoring system are cardiac complications, perforation of heart or cava, rupture of the pulmonary artery, and hemoptysis. Hence, rising incidences of complications associated with invasive monitoring systems are major restraining factors for the growth of the market.
Japan Dominates the Asia-Pacific Hemodynamic Monitoring Market
Japan is currently one of the largest markets in the world for hemodynamic monitoring. It is estimated that there are approximately 680,000 high-risk surgical patients, per annum, in Japan.
Japan has a lower number of intensive care units, as compared to the western countries. To improve the use of hemodynamic monitoring techniques, strong guidelines and protocols need to be implemented. Such guidelines could improve clinical outcomes and help anesthesiologists adopt perioperative cardiac output optimization universally, which is expected to drive the market studied over the forecast period.
Key Developments in the MarketLiDCO, the hemodynamic monitoring company, announces that it has been granted registration in Japan for its latest product, the LiDCOunity v2
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
7. Market Segmentation
8. Company Profiles & Competitive LandscapeEdwards Life Sciences Corporation Lidco Group PLC ICU Medical Inc. Schwarzer Cardiotek GmbH Philips Healthcare Cheetah Medical Inc. Getinge Group GE Healthcare Draeger Medical
9. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/f23rbh/asiapacific?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005871/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Devices,Intensive Care and Emergency Medicine,Patient Monitoring Equipment
KEYWORD: ASIA PACIFIC
INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 03:35 PM/DISC: 09/27/2018 03:35 PM